Giandomenica Iezzi

Lugano, TI, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications

Fusobacterium nucleatum and response to treatment in colon and rectal cancer: a systematic review.

Fusobacterium nucleatum and response to treatment in colon and rectal cancer: a systematic review.

Journal: Cancer treatment reviews
Published: May 21, 2026

Preoperative metronidazole treatment to evaluate its efficacy in reducing Fusobacterium nucleatum colonisation in colorectal cancer patients: a proof-of-concept trial.

Preoperative metronidazole treatment to evaluate its efficacy in reducing Fusobacterium nucleatum colonisation in colorectal cancer patients: a proof-of-concept trial.

Journal: ESMO gastrointestinal oncology
Published: February 06, 2026

Corrigendum to "iNKT cell-neutrophil crosstalk promotes colorectal cancer pathogenesis" [Mucosal Immunol. 16(3) (2023) 326-340.

Corrigendum to "iNKT cell-neutrophil crosstalk promotes colorectal cancer pathogenesis" [Mucosal Immunol. 16(3) (2023) 326-340.

Journal: Mucosal immunology
Published: December 11, 2025

A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma.

A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma.

Journal: Cancer cell
Published: September 28, 2025

Intratumoral microbiota and host genotype cooperatively shape neutrophil cytotoxic functions in colorectal cancer.

Intratumoral microbiota and host genotype cooperatively shape neutrophil cytotoxic functions in colorectal cancer.

Journal: Cell host & microbe
Published: May 05, 2025

Combined tumor-associated microbiome and immune gene expression profiling predict response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer.

Combined tumor-associated microbiome and immune gene expression profiling predict response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer.

Journal: Oncoimmunology
Published: February 24, 2025

Direct toll-like receptor triggering in colorectal cancer-associated stromal cells elicits immunostimulatory properties leading to enhanced immune cell recruitment.

Direct toll-like receptor triggering in colorectal cancer-associated stromal cells elicits immunostimulatory properties leading to enhanced immune cell recruitment.

Journal: Gut
Published: December 14, 2023

iNKT cell-neutrophil crosstalk promotes colorectal cancer pathogenesis.

iNKT cell-neutrophil crosstalk promotes colorectal cancer pathogenesis.

Journal: Mucosal immunology
Published: January 11, 2023

Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment.

Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment.

Journal: Life science alliance
Published: July 04, 2022

Identification of TPM2 and CNN1 as Novel Prognostic Markers in Functionally Characterized Human Colon Cancer-Associated Stromal Cells.

Identification of TPM2 and CNN1 as Novel Prognostic Markers in Functionally Characterized Human Colon Cancer-Associated Stromal Cells.

Journal: Cancers
Published: January 31, 2022

IL-22-mediates Cross-talk between Tumor Cells and Immune Cells Associated with Favorable Prognosis in Human Colorectal Cancer.

IL-22-mediates Cross-talk between Tumor Cells and Immune Cells Associated with Favorable Prognosis in Human Colorectal Cancer.

Journal: Journal of cellular immunology
Published: July 23, 2021

Infiltration by IL22-Producing T Cells Promotes Neutrophil Recruitment and Predicts Favorable Clinical Outcome in Human Colorectal Cancer.

Infiltration by IL22-Producing T Cells Promotes Neutrophil Recruitment and Predicts Favorable Clinical Outcome in Human Colorectal Cancer.

Journal: Cancer immunology research
Published: November 23, 2019
Showing 1-12 of 45

Last Updated: 09/26/2026